Search

Your search keyword '"Elia, Chiara A."' showing total 164 results
Start Over Author "Elia, Chiara A."
164 results on '"Elia, Chiara A."'

4. FRI-078-YI Long-term albumin administration in outpatients with decompensated cirrhosis and diabetes mellitus: post-hoc analysis of the ANSWER trial database

Author

Iannone, Giulia, primary, Zaccherini, Giacomo, additional, Pompili, Enrico, additional, Tedesco, Greta, additional, De Venuto, Clara, additional, Baldassarre, Maurizio, additional, Riggio, Oliviero, additional, Angeli, Paolo, additional, Alessandria, Carlo, additional, Neri, Sergio, additional, Foschi, Francesco, additional, Levantesi, Fabio, additional, Airoldi, Aldo, additional, Simone, Loredana, additional, Svegiati-Baroni, Gianluca, additional, Fagiuoli, Stefano, additional, Laffi, Giacomo, additional, Cozzolongo, Raffaele, additional, Di Marco, Vito, additional, Sangiovanni, Vincenzo, additional, Morisco, Filomena, additional, Toniutto, Pierluigi, additional, Tortora, Annalisa, additional, De Marco, Rosanna, additional, Nardelli, Silvia, additional, Piano, Salvatore, additional, Elia, Chiara, additional, Caraceni, Paolo, additional, and Bernardi, Mauro, additional

Published
2024
Full Text
View/download PDF

7. Evaluation of Clensia®, a new low-volume PEG bowel preparation in colonoscopy: Multicentre randomized controlled trial versus 4L PEG

Author

Spada, Cristiano, Cesaro, Paola, Bazzoli, Franco, Saracco, Giorgio Maria, Cipolletta, Livio, Buri, Luigi, Crosta, Cristiano, Petruzziello, Lucio, Ceroni, Liza, Fuccio, Lorenzo, Giordanino, Chiara, Elia, Chiara, Rotondano, Gianluca, Bianco, Maria A., Simeth, Catrin, Consalvo, Danilo, De Roberto, Giuseppe, Fiori, Giancarla, Campanale, Mariachiara, and Costamagna, Guido

Published
2017
Full Text
View/download PDF

8. Validation of a Staging System for Acute Kidney Injury in Patients With Cirrhosis and Association With Acute-on-Chronic Liver Failure

Author

Huelin, Patricia, Piano, Salvatore, Solà, Elsa, Stanco, Marialuisa, Solé, Cristina, Moreira, Rebeca, Pose, Elisa, Fasolato, Silvano, Fabrellas, Nuria, de Prada, Glòria, Pilutti, Chiara, Graupera, Isabel, Ariza, Xavier, Romano, Antonietta, Elia, Chiara, Cárdenas, Andrés, Fernández, Javier, Angeli, Paolo, and Ginès, Pere

Published
2017
Full Text
View/download PDF

14. Correction and prevention of hyponatremia in patients with cirrhosis and ascites-post hoc analysis of the ANSWER study database

Author

Zaccherini, Giacomo, primary, Baldassarre, Maurizio, additional, Tufoni, Manuel, additional, Riggio, Oliviero, additional, Angeli, Paolo, additional, Alessandria, Carlo, additional, Neri, Sergio, additional, Foschi, Francesco Giuseppe, additional, Levantesi, Fabio, additional, Airoldi, Aldo, additional, Simone, Loredana, additional, Svegiati-Baroni, Gianluca, additional, Fagiuoli, Stefano, additional, Laffi, Giacomo, additional, Cozzolongo, Raffaele, additional, Di Marco, Vito, additional, Sangiovanni, Vincenzo, additional, Morisco, Filomena, additional, Toniutto, Pierluigi, additional, Tortora, Annalisa, additional, De Marco, Rosanna, additional, Nardelli, Silvia, additional, Piano, Salvatore, additional, Elia, Chiara, additional, Bernardi, Mauro, additional, and Caraceni, Paolo, additional

Published
2022
Full Text
View/download PDF

15. Correction and prevention of hyponatremia in patients with cirrhosis and ascites-post hoc analysis of the ANSWER study database

Author

Giacomo Zaccherini, Baldassarre, Maurizio, Tufoni, Manuel, Riggio, Oliviero, Angeli, Paolo, Alessandria, Carlo, Neri, Sergio, Foschi, Francesco Giuseppe, Levantesi, Fabio, Airoldi, Aldo, Simone, Loredana, Svegiati-Baroni, Gianluca, Fagiuoli, Stefano, Laffi, Giacomo, Cozzolongo, Raffaele, Di Marco, Vito, Sangiovanni, Vincenzo, Morisco, Filomena, Toniutto, Pierluigi, Tortora, Annalisa, Marco, Rosanna, Nardelli, Silvia, Piano, Salvatore, Elia, Chiara, Bernardi, Mauro, and Caraceni, Paolo

Subjects
Hepatology
Published
2022
Full Text
View/download PDF

17. Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis

Author

Juanola, Adrià, primary, Graupera, Isabel, additional, Elia, Chiara, additional, Piano, Salvatore, additional, Solé, Cristina, additional, Carol, Marta, additional, Pérez-Guasch, Martina, additional, Bassegoda, Octavi, additional, Escudé, Laia, additional, Rubio, Ana-Belén, additional, Cervera, Marta, additional, Napoleone, Laura, additional, Avitabile, Emma, additional, Ma, Ann T., additional, Fabrellas, Núria, additional, Pose, Elisa, additional, Morales-Ruiz, Manuel, additional, Jiménez, Wladimiro, additional, Torres, Ferran, additional, Crespo, Gonzalo, additional, Solà, Elsa, additional, and Ginès, Pere, additional

Published
2022
Full Text
View/download PDF

22. Voice quality after transoral CO2 laser microsurgery (TOLMS): systematic review of literature.

Author

Colizza, Andrea, Ralli, Massimo, D'Elia, Chiara, Greco, Antonio, and de Vincentiis, Marco

Subjects
VOICE disorders, MICROSURGERY, LARYNGOPLASTY, LASERS, CARBON dioxide, HUMAN voice, AERODYNAMICS
Abstract

Purpose: Transoral laser microsurgery (TOLMS) with carbon dioxide is a safe approach for laryngeal carcinoma. In literature there are three main methods for evaluating speech outcomes: acoustic and aerodynamics analysis, perceptual evaluation and patient-reported outcomes (PROs). The aim of this study was to systematically review the literature about the voice quality outcomes of TOLMS according to type of cordectomy. Methods: A systematic literature review was performed and all the results until December 2021 were extrapolated. We evaluated the acoustic and aerodynamics parameters (fundamental frequency, harmonics to noise ratio, jitter, shimmer and maximum phonation time), perceptual data (GRBAS scale) and patient-related outcomes (VHI scale). Results: 24 studies met the inclusion criteria for a total number of 1207 patients enrolled. The number for each type of cordectomy are: 287 type I (23.78%), 311 type II (25.78%), 328 type III (27.14%), 129 type 4 (10.69%) and 152 type V (12.60%). Patients are grouped according to the type of cordectomy in: limited cordectomy (type I and II) and extended cordectomy (types III–IV–V). The difference between two groups is statistically significative in terms of acoustic analysis, perceptual data and patient-related outcomes (p < 0.05). Conclusions: Patients who underwent type I or II cordectomy have significantly better quality of voice in terms of VHI, perceptual voice quality evaluations and acoustic parameters compared to type III, IV and V cordectomies. The effect of TOLMS on the voice should depend from the extent of the resection and in particular from the scar of the vocal muscle. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

23. Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients

Author

Gerussi, A, Rigamonti, C, Elia, C, Cazzagon, N, Floreani, A, Pozzi, R, Pozzoni, P, Claar, E, Pasulo, L, Fagiuoli, S, Cristoferi, L, Carbone, M, Invernizzi, P, Gerussi, Alessio, Rigamonti, Cristina, Elia, Chiara, Cazzagon, Nora, Floreani, Annarosa, Pozzi, Roberta, Pozzoni, Pietro, Claar, Ernesto, Pasulo, Luisa, Fagiuoli, Stefano, Cristoferi, Laura, Carbone, Marco, Invernizzi, Pietro, Gerussi, A, Rigamonti, C, Elia, C, Cazzagon, N, Floreani, A, Pozzi, R, Pozzoni, P, Claar, E, Pasulo, L, Fagiuoli, S, Cristoferi, L, Carbone, M, Invernizzi, P, Gerussi, Alessio, Rigamonti, Cristina, Elia, Chiara, Cazzagon, Nora, Floreani, Annarosa, Pozzi, Roberta, Pozzoni, Pietro, Claar, Ernesto, Pasulo, Luisa, Fagiuoli, Stefano, Cristoferi, Laura, Carbone, Marco, and Invernizzi, Pietro

Abstract

Chronic immunosuppression is associated with increased and more severe viral infections. However, little is known about the association between immunosuppression and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Our aim was to describe the clinical course of patients with immunosuppressed autoimmune hepatitis (AIH) during coronavirus disease 2019 (COVID-19) infection in Italy. Our study is a case series of patients with AIH treated with immunosuppression, who tested positive for SARS-CoV-2 in March 2020 during the outbreak of COVID-19. Ten patients from seven different hospitals in Italy were diagnosed with COVID-19 during the outbreak of SARS-CoV-2 in March 2020. Seven subjects were female (70%), and age ranged from 27 to 73 years. Before the onset of SARS-CoV-2 infection, all patients were taking immunosuppressive therapy for AIH, and eight of them were on biochemical remission. Two other patients had recent acute onset of their AIH, and consequently started high-dose steroids, as per induction protocol. All patients had a respiratory syndrome and a positive nasal swab for SARS-CoV-2. Five patients developed a computed tomography-confirmed COVID-19 pneumonia. Six subjects received a combination of antiretroviral and antimalarial drugs. In seven patients, the dosage of immunosuppressive medication was changed. Liver enzymes were repeated during SARS-CoV-2 infection in all hospitalized cases; they remained within the normal range in all cases, and improved in the two acute cases treated with high-dose steroids. The clinical outcome was comparable to the reported cases occurring in non-immunosuppressed subjects.Conclusion:Patients under immunosuppressive therapy for AIH developing COVID-19 show a disease course presumptively similar to that reported in the non-immunosuppressed population. These data might aid in medical decisions when dealing with SARS-CoV-2 infection in immunocompromised patients.

Published
2020

24. On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites

Author

Caraceni, Paolo, Tufoni, Manuel, Zaccherini, Giacomo, Riggio, Oliviero, Angeli, Paolo, Alessandria, Carlo, Neri, Sergio, Foschi, Francesco G, Levantesi, Fabio, Airoldi, Aldo, Simone, Loredana, Svegliati-Baroni, Gianluca, Fagiuoli, Stefano, Laffi, Giacomo, Cozzolongo, Raffaele, Di Marco, Vito, Sangiovanni, Vincenzo, Morisco, Filomena, Toniutto, Pierluigi, Gasbarrini, Antonio, De Marco, Rosanna, Piano, Salvatore, Nardelli, Silvia, Elia, Chiara, Roncadori, Andrea, Baldassarre, Maurizio, Bernardi, Mauro, Gasbarrini, Antonio (ORCID:0000-0002-7278-4823), Caraceni, Paolo, Tufoni, Manuel, Zaccherini, Giacomo, Riggio, Oliviero, Angeli, Paolo, Alessandria, Carlo, Neri, Sergio, Foschi, Francesco G, Levantesi, Fabio, Airoldi, Aldo, Simone, Loredana, Svegliati-Baroni, Gianluca, Fagiuoli, Stefano, Laffi, Giacomo, Cozzolongo, Raffaele, Di Marco, Vito, Sangiovanni, Vincenzo, Morisco, Filomena, Toniutto, Pierluigi, Gasbarrini, Antonio, De Marco, Rosanna, Piano, Salvatore, Nardelli, Silvia, Elia, Chiara, Roncadori, Andrea, Baldassarre, Maurizio, Bernardi, Mauro, and Gasbarrini, Antonio (ORCID:0000-0002-7278-4823)

Abstract

N/A

Published
2020

25. On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites

Author

Caraceni, Paolo, primary, Tufoni, Manuel, additional, Zaccherini, Giacomo, additional, Riggio, Oliviero, additional, Angeli, Paolo, additional, Alessandria, Carlo, additional, Neri, Sergio, additional, Foschi, Francesco G., additional, Levantesi, Fabio, additional, Airoldi, Aldo, additional, Simone, Loredana, additional, Svegliati-Baroni, Gianluca, additional, Fagiuoli, Stefano, additional, Laffi, Giacomo, additional, Cozzolongo, Raffaele, additional, Di Marco, Vito, additional, Sangiovanni, Vincenzo, additional, Morisco, Filomena, additional, Toniutto, Pierluigi, additional, Gasbarrini, Antonio, additional, De Marco, Rosanna, additional, Piano, Salvatore, additional, Nardelli, Silvia, additional, Elia, Chiara, additional, Roncadori, Andrea, additional, Baldassarre, Maurizio, additional, Bernardi, Mauro, additional, Domenicali, Marco, additional, Giannone, Ferdinando A., additional, Antognoli, Agnese, additional, Merli, Manuela, additional, Pasquale, Chiara, additional, Gioia, Stefania, additional, Fasolato, Silvano, additional, Sticca, Antonietta, additional, Campion, Daniela, additional, Risso, Alessandro, additional, Saracco, Giorgio M., additional, Prestianni, Loredana, additional, Fidone, Federica, additional, Maiorca, Daniela, additional, Rizzotto, Agostino, additional, Cappa, Federica Mirici, additional, Lanzi, Arianna, additional, Neri, Elga, additional, Visani, Anna, additional, Mastroianni, Antonio, additional, Perricone, Giovanni, additional, Alberti, Alberto B., additional, Cesarini, Lucia, additional, Mazzarelli, Chiara, additional, Vangeli, Marcello, additional, Viganò, Raffaella, additional, Marzioni, Marco, additional, Capretti, Francesca, additional, Kostandini, Alba, additional, Magini, Giulia, additional, Colpani, Maria, additional, Gabbani, Tommaso, additional, Marsico, Maria, additional, Zappimbulso, Marianna, additional, Petruzzi, Josè, additional, Calvaruso, Vincenza, additional, Parrella, Giovanni, additional, Caporaso, Nicola, additional, Auriemma, Francesco, additional, Guarino, Maria, additional, Pugliese, Fabio, additional, Tortora, Annalisa, additional, Leo, Pietro, additional, Angelico, Mario, additional, De Leonardis, Francesco, additional, Pecchioli, Alessandra, additional, Rossi, Piera, additional, Raimondo, Giovanni, additional, Cacciola, Irene, additional, Elia, Gianfranco, additional, Negri, Elisa, additional, Dallio, Marcello, additional, Loguercio, Carmelina, additional, Federico, Alessandro, additional, Conte, Dario, additional, Massironi, Sara, additional, Natascia Celli, Giorgio Ballardini, additional, Rendina, Maria, additional, Bringiotti, Roberto, additional, Castellaneta, Nicola Maurizio, additional, Salerno, Francesco, additional, Boccia, Sergio, additional, Guarisco, Riccardo, additional, Galioto, Alessandra, additional, Cavallin, Marta, additional, and Andrealli, Alida, additional

Published
2021
Full Text
View/download PDF

26. Peri-implant Soft Tissue Stability After Single Implant Restorations Using Either Guided Bone Regeneration or a Connective Tissue Graft: A Randomized Clinical Trial.

Author

D'Elia, Chiara, Baldini, Nicola, Cagidiaco, Edoardo Ferrari, Nofri, Giacomo, Goracci, Cecilia, and de Sanctis, Massimo

Subjects
BONE regeneration, CONNECTIVE tissues, SKIN grafting, DENTAL implants, OPERATIVE dentistry, SURGERY, PHYSIOLOGY
Abstract

The purpose of the present study was to compare two different surgical procedures, connective tissue graft and guided bone regeneration, when applied in conjunction with implant placement. Probing pocket depth and the recession depth were recorded at the implant site after crown placement (T₁) and at the 1-year follow-up (T₂), while the keratinized tissue height and the buccal mucosa thickness were recorded at three different time points: at the time of implant surgery (T₀), after crown placement, and at the 1-year follow-up. No statistically significant differences in peri-implant mucosa thickness, recession, or other periodontal parameters were recorded at adjacent teeth. [ABSTRACT FROM AUTHOR]

Published
2017
Full Text
View/download PDF

28. Long-term albumin administration is not futile in patients with cirrhosis and uncomplicated ascites not normalizing serum albumin concentration with treatment

Author

Tufoni, Manuel, primary, Caraceni, Paolo, additional, Zaccherini, Giacomo, additional, Riggio, Oliviero, additional, Angeli, Paolo, additional, Alessandria, Carlo, additional, Neri, Sergio, additional, Foschi, Francesco Giuseppe, additional, Levantesi, Fabio, additional, Airoldi, Aldo, additional, Simone, Loredana, additional, Svegiati-Baroni, Gianluca, additional, Fagiuoli, Stefano, additional, Laffi, Giacomo, additional, Cozzolongo, Raffaele, additional, Di Marco, Vito, additional, Sangiovanni, Vincenzo, additional, Morisco, Filomena, additional, Toniutto, Pierluigi, additional, Tortora, Annalisa, additional, De Marco, Rosanna, additional, Nardelli, Silvia, additional, Piano, Salvatore, additional, Elia, Chiara, additional, Roncadori, Andrea, additional, Baldassarre, Maurizio, additional, and Bernardi, Mauro, additional

Published
2020
Full Text
View/download PDF

29. Urinary liver fatty-acid binding protein (UL-FABP) predicts acute-on-chronic liver failure (ACLF) and mortality in patients with decompensated cirrhosis

Author

Juanola, Adria, primary, Graupera, Isabel, additional, Piano, Salvatore, additional, Elia, Chiara, additional, Solé, Cristina, additional, Bassegoda, Octavi, additional, Carol, Marta, additional, Fabrellas, Núria, additional, Cervera, Marta, additional, Perez, Martina, additional, Napoleone, Laura, additional, Pose, Elisa, additional, Torres, Ferran, additional, Solà, Elsa, additional, and Ginès, Pere, additional

Published
2020
Full Text
View/download PDF

30. Coronavirus Disease 2019 in Autoimmune Hepatitis: A Lesson From Immunosuppressed Patients

Author

Gerussi, Alessio, primary, Rigamonti, Cristina, additional, Elia, Chiara, additional, Cazzagon, Nora, additional, Floreani, Annarosa, additional, Pozzi, Roberta, additional, Pozzoni, Pietro, additional, Claar, Ernesto, additional, Pasulo, Luisa, additional, Fagiuoli, Stefano, additional, Cristoferi, Laura, additional, Carbone, Marco, additional, and Invernizzi, Pietro, additional

Published
2020
Full Text
View/download PDF

31. Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease

Author

Losurdo, Morris, primary, Pedrazzoli, Matteo, additional, D'Agostino, Claudia, additional, Elia, Chiara A., additional, Massenzio, Francesca, additional, Lonati, Elena, additional, Mauri, Mario, additional, Rizzi, Laura, additional, Molteni, Laura, additional, Bresciani, Elena, additional, Dander, Erica, additional, D'Amico, Giovanna, additional, Bulbarelli, Alessandra, additional, Torsello, Antonio, additional, Matteoli, Michela, additional, Buffelli, Mario, additional, and Coco, Silvia, additional

Published
2020
Full Text
View/download PDF

34. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

Author

Caraceni, Paolo, Riggio, Oliviero, Angeli, Paolo, Alessandria, Carlo, Neri, Sergio, Foschi, Francesco G, Levantesi, Fabio, Airoldi, Aldo, Boccia, Sergio, Svegliati-Baroni, Gianluca, Fagiuoli, Stefano, Romanelli, Roberto G, Cozzolongo, Raffaele, Di Marco, Vito, Sangiovanni, Vincenzo, Morisco, Filomena, Toniutto, Pierluigi, Tortora, Annalisa, De Marco, Rosanna, Angelico, Mario, Cacciola, Irene, Elia, Gianfranco, Federico, Alessandro, Massironi, Sara, Guarisco, Riccardo, Galioto, Alessandra, Ballardini, Giorgio, Rendina, Maria, Nardelli, Silvia, Piano, Salvatore, Elia, Chiara, Prestianni, Loredana, Cappa, Federica Mirici, Cesarini, Lucia, Simone, Loredana, Pasquale, Chiara, Cavallin, Marta, Andrealli, Alida, Fidone, Federica, Ruggeri, Matteo, Roncadori, Andrea, Baldassarre, Maurizio, Tufoni, Manuel, Zaccherini, Giacomo, Bernardi, Mauro, Domenicali, Marco, Giannone, Ferdinando A, Merli, Manuela, Gioia, Stefania, Fasolato, Silvano, Sticca, Antonietta, Campion, Daniela, Risso, Alessandro, Saracco, Giorgio M, Maiorca, Daniela, Rizzotto, Agostino, Lanzi, Arianna, Neri, Elga, Visani, Anna, Mastroianni, Antonio, Alberti, Alberto B, Mazzarelli, Chiara, Vangeli, Marcello, Marzioni, Marco, Capretti, Francesca, Kostandini, Alba, Magini, Giulia, Colpani, Maria, Laffi, Giacomo, Gabbani, Tommaso, Marsico, Maria, Zappimbulso, Marianna, Petruzzi, Josè, Calvaruso, Vincenza, Parrella, Giovanni, Caporaso, Nicola, Auriemma, Francesco, Guarino, Maria, Pugliese, Fabio, Gasbarrini, Antonio, Leo, Pietro, De Leonardis, Francesco, Pecchioli, Alessandra, Rossi, Piera, Raimondo, Giovanni, Negri, Elisa, Dallio, Marcello, Loguercio, Carmelina, Conte, Dario, Celli, Natascia, Bringiotti, Roberto, Castellaneta, Nicola M, Salerno, Francesco, ANSWER Study Investigators, Caraceni, Paolo, Riggio, Oliviero, Angeli, Paolo, Alessandria, Carlo, Neri, Sergio, Foschi, Francesco G, Levantesi, Fabio, Airoldi, Aldo, Boccia, Sergio, Svegliati-Baroni, Gianluca, Fagiuoli, Stefano, Romanelli, Roberto G, Cozzolongo, Raffaele, Di Marco, Vito, Sangiovanni, Vincenzo, Morisco, Filomena, Toniutto, Pierluigi, Tortora, Annalisa, De Marco, Rosanna, Angelico, Mario, Cacciola, Irene, Elia, Gianfranco, Federico, Alessandro, Massironi, Sara, Guarisco, Riccardo, Galioto, Alessandra, Ballardini, Giorgio, Rendina, Maria, Nardelli, Silvia, Piano, Salvatore, Elia, Chiara, Prestianni, Loredana, Cappa, Federica Mirici, Cesarini, Lucia, Simone, Loredana, Pasquale, Chiara, Cavallin, Marta, Andrealli, Alida, Fidone, Federica, Ruggeri, Matteo, Roncadori, Andrea, Baldassarre, Maurizio, Tufoni, Manuel, Zaccherini, Giacomo, Bernardi, Mauro, Domenicali, Marco, Giannone, Ferdinando A, Merli, Manuela, Gioia, Stefania, Fasolato, Silvano, Sticca, Antonietta, Campion, Daniela, Risso, Alessandro, Saracco, Giorgio M, Maiorca, Daniela, Rizzotto, Agostino, Lanzi, Arianna, Neri, Elga, Visani, Anna, Mastroianni, Antonio, Alberti, Alberto B, Mazzarelli, Chiara, Vangeli, Marcello, Marzioni, Marco, Capretti, Francesca, Kostandini, Alba, Magini, Giulia, Colpani, Maria, Laffi, Giacomo, Gabbani, Tommaso, Marsico, Maria, Zappimbulso, Marianna, Petruzzi, Josè, Calvaruso, Vincenza, Parrella, Giovanni, Caporaso, Nicola, Auriemma, Francesco, Guarino, Maria, Pugliese, Fabio, Gasbarrini, Antonio, Leo, Pietro, De Leonardis, Francesco, Pecchioli, Alessandra, Rossi, Piera, Raimondo, Giovanni, Negri, Elisa, Dallio, Marcello, Loguercio, Carmelina, Conte, Dario, Celli, Natascia, Bringiotti, Roberto, Castellaneta, Nicola M, Salerno, Francesco, Caraceni P1, Riggio O2, Angeli P3, Alessandria C4, Neri S5, Foschi FG6, Levantesi F7, Airoldi A8, Boccia S9, Svegliati-Baroni G10, Fagiuoli S11, Romanelli RG12, Cozzolongo R13, Di Marco Vito, Sangiovanni V15, Morisco F16, Toniutto P17, Tortora A18, De Marco R19, Angelico M20, Cacciola I21, Elia G22, Federico A23, Massironi S24, Guarisco R25, Galioto A26, Ballardini G27, Rendina M28, Nardelli S2, Piano S3, Elia C4, Prestianni L5, Cappa FM6, Cesarini L8, Simone L9, Pasquale C2, Cavallin M3, Andrealli A4, Fidone F5, Ruggeri M29, Roncadori A30, Baldassarre M1, Tufoni M1, Zaccherini G1, Bernardi M31, Domenicali M, Giannone FA, Merli M, Gioia S, Fasolato S, Sticca A, Campion D, Risso A, Saracco GM, Maiorca D, Rizzotto A, Lanzi A, Neri E, Visani A, Mastroianni A, Alberti AB, Mazzarelli C, Vangeli M, Marzioni M, Capretti F, Kostandini A, Magini G, Colpani M, Laffi G, Gabbani T, Marsico M, Zappimbulso M, Petruzzi J, Calvaruso Vincenza, Parrella G, Caporaso N, Auriemma F, Guarino M, Pugliese F, Gasbarrini A, Leo P, De Leonardis F, Pecchioli A, Rossi P, Raimondo G, Negri E, Dallio M, Loguercio C, Conte D, Celli N, Bringiotti R, Castellaneta NM, Salerno F., Caraceni P, Riggio O, Angeli P, Alessandria C, Neri S, Foschi FG, Levantesi F, Airoldi A, Boccia S, Svegliati-Baroni G, Fagiuoli S, Romanelli RG, Cozzolongo R, Di Marco V, Sangiovanni V, Morisco F, Toniutto P, Tortora A, De Marco R, Angelico M, Cacciola I, Elia G, Federico A, Massironi S, Guarisco R, Galioto A, Ballardini G, Rendina M, Nardelli S, Piano S, Elia C, Prestianni L, Cappa FM, Cesarini L, Simone L, Pasquale C, Cavallin M, Andrealli A, Fidone F, Ruggeri M, Roncadori A, Baldassarre M, Tufoni M, Zaccherini G, Bernardi M, Domenicali M, Giannone FA, Merli M, Gioia S, Fasolato S, Sticca A, Campion D, Risso A, Saracco GM, Maiorca D, Rizzotto A, Lanzi A, Neri E, Visani A, Mastroianni A, Alberti AB, Mazzarelli C, Vangeli M, Marzioni M, Capretti F, Kostandini A, Magini G, Colpani M, Laffi G, Gabbani T, Marsico M, Zappimbulso M, Petruzzi J, Calvaruso V, Parrella G, Caporaso N, Auriemma F, Guarino M, Pugliese F, Gasbarrini A, Leo P, De Leonardis F, Pecchioli A, Rossi P, Raimondo G, Negri E, Dallio M, Loguercio C, Conte D, Celli N, Bringiotti R, Castellaneta NM, Salerno F., Caraceni, P, Riggio, O, Angeli, P, Alessandria, C, Neri, S, Foschi, F, Levantesi, F, Airoldi, A, Boccia, S, Svegliati-Baroni, G, Fagiuoli, S, Romanelli, R, Cozzolongo, R, Di Marco, V, Sangiovanni, V, Morisco, F, Toniutto, P, Tortora, A, De Marco, R, Angelico, M, Cacciola, I, Elia, G, Federico, A, Massironi, S, Guarisco, R, Galioto, A, Ballardini, G, Rendina, M, Nardelli, S, Piano, S, Elia, C, Prestianni, L, Cappa, F, Cesarini, L, Simone, L, Pasquale, C, Cavallin, M, Andrealli, A, Fidone, F, Ruggeri, M, Roncadori, A, Baldassarre, M, Tufoni, M, Zaccherini, G, Bernardi, M, Domenicali, M, Giannone, F, Merli, M, Gioia, S, Fasolato, S, Sticca, A, Campion, D, Risso, A, Saracco, G, Maiorca, D, Rizzotto, A, Lanzi, A, Neri, E, Visani, A, Mastroianni, A, Alberti, A, Mazzarelli, C, Vangeli, M, Marzioni, M, Capretti, F, Kostandini, A, Magini, G, Colpani, M, Laffi, G, Gabbani, T, Marsico, M, Zappimbulso, M, Petruzzi, J, Calvaruso, V, Parrella, G, Caporaso, N, Auriemma, F, Guarino, M, Pugliese, F, Gasbarrini, A, Leo, P, De Leonardis, F, Pecchioli, A, Rossi, P, Raimondo, G, Negri, E, Dallio, M, Loguercio, C, Conte, D, Celli, N, Bringiotti, R, Castellaneta, N, and Salerno, F

Subjects
Liver Cirrhosis, Male, Time Factors, Cirrhosis, Kaplan-Meier Estimate, law.invention, ascites, 0302 clinical medicine, Hepatorenal syndrome, Randomized controlled trial, Furosemide, law, Ascites, Clinical endpoint, Paracentesis, Diuretics, albumin, decompensated cirrhosi, Mineralocorticoid Receptor Antagonists, Settore MED/12 - Gastroenterologia, Medicine (all), Hazard ratio, General Medicine, Middle Aged, Survival Rate, 030220 oncology & carcinogenesis, Drug Therapy, Combination, Female, 030211 gastroenterology & hepatology, Quality-Adjusted Life Years, medicine.symptom, Hyponatremia, medicine.medical_specialty, 03 medical and health sciences, Albumins, Internal medicine, medicine, Humans, Survival rate, albumin, Aged, business.industry, cirrhosis, medicine.disease, Clinical trial, albumin, cirrhosis, ascites, liver decompensation, Quality of Life, Hyperkalemia, business, Esophagus Varices, Portal Hypertension, Varicosis
Abstract

Background Evidence is scarce on the efficacy of long-term human albumin (HA) administration in patients with decompensated cirrhosis. The human Albumin for the treatmeNt of aScites in patients With hEpatic ciRrhosis (ANSWER) study was designed to clarify this issue. Methods We did an investigator-initiated multicentre randomised, parallel, open-label, pragmatic trial in 33 academic and non-academic Italian hospitals. We randomly assigned patients with cirrhosis and uncomplicated ascites who were treated with anti-aldosteronic drugs (≥200 mg/day) and furosemide (≥25 mg/day) to receive either standard medical treatment (SMT) or SMT plus HA (40 g twice weekly for 2 weeks, and then 40 g weekly) for up to 18 months. The primary endpoint was 18-month mortality, evaluated as difference of events and analysis of survival time in patients included in the modified intention-to-treat and per-protocol populations. This study is registered with EudraCT, number 2008–000625–19, and ClinicalTrials.gov, number NCT01288794. Findings From April 2, 2011, to May 27, 2015, 440 patients were randomly assigned and 431 were included in the modified intention-to-treat analysis. 38 of 218 patients died in the SMT plus HA group and 46 of 213 in the SMT group. Overall 18-month survival was significantly higher in the SMT plus HA than in the SMT group (Kaplan-Meier estimates 77% vs 66%; p=0·028), resulting in a 38% reduction in the mortality hazard ratio (0·62 [95% CI 0·40–0·95]). 46 (22%) patients in the SMT group and 49 (22%) in the SMT plus HA group had grade 3–4 non-liver related adverse events. Interpretation In this trial, long-term HA administration prolongs overall survival and might act as a disease modifying treatment in patients with decompensated cirrhosis. Funding Italian Medicine Agency. Copyright © 2018 Elsevier Ltd. All rights reserved.

Published
2018

36. SAT535 - Correction and prevention of hyponatremia in patients with cirrhosis and ascites-post hoc analysis of the ANSWER study database

Author

Zaccherini, Giacomo, Baldassarre, Maurizio, Tufoni, Manuel, Riggio, Oliviero, Angeli, Paolo, Alessandria, Carlo, Neri, Sergio, Foschi, Francesco Giuseppe, Levantesi, Fabio, Airoldi, Aldo, Simone, Loredana, Svegiati-Baroni, Gianluca, Fagiuoli, Stefano, Laffi, Giacomo, Cozzolongo, Raffaele, Di Marco, Vito, Sangiovanni, Vincenzo, Morisco, Filomena, Toniutto, Pierluigi, Tortora, Annalisa, De Marco, Rosanna, Nardelli, Silvia, Piano, Salvatore, Elia, Chiara, Bernardi, Mauro, and Caraceni, Paolo

Published
2022
Full Text
View/download PDF

37. Characteristics and management of pyogenic liver abscess

Author

Serraino, Cristina, Elia, Chiara, Bracco, Christian, Rinaldi, Gianluca, Pomero, Fulvio, Silvestri, Alberto, Melchio, Remo, and Fenoglio, Luigi Maria

Subjects
Adult, Male, Biliary Fistula, clinical presentation, Observational Study, Postoperative Complications, pyogenic liver abscess, Escherichia coli, risk factors, Humans, percutaneous drainage, microbiology, Pneumothorax, Streptococcus, Middle Aged, Magnetic Resonance Imaging, Anti-Bacterial Agents, Outcome and Process Assessment, Health Care, Italy, Liver, Liver Abscess, Pyogenic, Drainage, Female, Tomography, X-Ray Computed, Research Article
Abstract

Pyogenic liver abscess (PLA) are space-occupying lesions in the liver associated with high morbidity and mortality. The aim of this study is to review an Italian hospital experience in epidemiological, clinical patterns, and management of PLA. We performed a retrospective, descriptive case series at a single center assessing demographic characteristics, presentation patterns, etiological factors, microbiological etiology, and management for patients treated for PLA between 2000 and 2016. Around 109 patients were identified. The majority of patients presented with fever (73%); right upper abdominal pain in 63.3%, vomiting and nausea in 28.4%. The most common laboratory abnormality among included items was increased C-reactive protein and fibrinogen blood levels, respectively, in 98% and 93.9% of cases. Abdominal ultrasound was the diagnostic investigation in 42.4% of cases; CT scan and MR imaging were performed in 51.1% and 3.3% of cases respectively. We observed blood or pus culture study in 99 cases of which only 53.5% came with positive microbial reports. The most common organism identified was Escherichia coli (26.5%), followed by Streptococcus spp (13.2%). Early antibiotic treatment started on all patients and 66.7% of cases required different approaches, Ultrasound or CT-guided needle aspiration of PLA was performed in 13 patients (11%) and percutaneous abscess drainage was performed on 72 patients (67%). PLA is a diagnostically challenging problem due to nonspecific presenting characteristics. The microbiological yield identified was a typical European spectrum with a preponderance of Escherichia coli infections. Once recognized, percutaneous drainage and antibiotic treatment are the mainstay of management for PLA.

Published
2018

39. Intracerebral Injection of Extracellular Vesicles from Mesenchymal Stem Cells Exerts Reduced Aβ Plaque Burden in Early Stages of a Preclinical Model of Alzheimer’s Disease

Author

Elia, Chiara A., primary, Tamborini, Matteo, additional, Rasile, Marco, additional, Desiato, Genni, additional, Marchetti, Sara, additional, Swuec, Paolo, additional, Mazzitelli, Sonia, additional, Clemente, Francesca, additional, Anselmo, Achille, additional, Matteoli, Michela, additional, Malosio, Maria Luisa, additional, and Coco, Silvia, additional

Published
2019
Full Text
View/download PDF

40. Neutrophil Gelatinase‐Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective Study

Author

Huelin, Patricia, primary, Solà, Elsa, additional, Elia, Chiara, additional, Solé, Cristina, additional, Risso, Alessandro, additional, Moreira, Rebeca, additional, Carol, Marta, additional, Fabrellas, Núria, additional, Bassegoda, Octavi, additional, Juanola, Adrià, additional, de Prada, Gloria, additional, Albertos, Sonia, additional, Piano, Salvatore, additional, Graupera, Isabel, additional, Ariza, Xavier, additional, Napoleone, Laura, additional, Pose, Elisa, additional, Filella, Xavier, additional, Morales‐Ruiz, Manuel, additional, Rios, José, additional, Fernández, Javier, additional, Jiménez, Wladimiro, additional, Poch, Esteban, additional, Torres, Ferran, additional, and Ginès, Pere, additional

Published
2019
Full Text
View/download PDF

41. PS-083-Serum albumin concentration as guide for long-term albumin treatment in patients with cirrhosis and uncomplicated ascites: Lessons from the ANSWER study

Author

Caraceni, Paolo, primary, Riggio, Oliviero, additional, Angeli, Paolo, additional, Alessandria, Carlo, additional, Neri, Sergio, additional, Foschi, Francesco Giuseppe, additional, Levantesi, Fabio, additional, Airoldi, Aldo, additional, Simone, Loredana, additional, Svegiati-Baroni, Gianluca, additional, Fagiuoli, Stefano, additional, Romanelli, Roberto Giulio, additional, Cozzolongo, Raffaele, additional, Marco, Vito Di, additional, Sangiovanni, Vincenzo, additional, Morisco, Filomena, additional, Toniutto, Pierluigi, additional, Tortora, Annalisa, additional, Marco, Rosanna De, additional, Nardelli, Silvia, additional, Piano, Salvatore, additional, Elia, Chiara, additional, Roncadori, Andrea, additional, Tufoni, Manuel, additional, Zaccherini, Giacomo, additional, and Bernardi, Mauro, additional

Published
2019
Full Text
View/download PDF

43. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

Author

Caraceni, Paolo, primary, Riggio, Oliviero, additional, Angeli, Paolo, additional, Alessandria, Carlo, additional, Neri, Sergio, additional, Foschi, Francesco G, additional, Levantesi, Fabio, additional, Airoldi, Aldo, additional, Boccia, Sergio, additional, Svegliati-Baroni, Gianluca, additional, Fagiuoli, Stefano, additional, Romanelli, Roberto G, additional, Cozzolongo, Raffaele, additional, Di Marco, Vito, additional, Sangiovanni, Vincenzo, additional, Morisco, Filomena, additional, Toniutto, Pierluigi, additional, Tortora, Annalisa, additional, De Marco, Rosanna, additional, Angelico, Mario, additional, Cacciola, Irene, additional, Elia, Gianfranco, additional, Federico, Alessandro, additional, Massironi, Sara, additional, Guarisco, Riccardo, additional, Galioto, Alessandra, additional, Ballardini, Giorgio, additional, Rendina, Maria, additional, Nardelli, Silvia, additional, Piano, Salvatore, additional, Elia, Chiara, additional, Prestianni, Loredana, additional, Cappa, Federica Mirici, additional, Cesarini, Lucia, additional, Simone, Loredana, additional, Pasquale, Chiara, additional, Cavallin, Marta, additional, Andrealli, Alida, additional, Fidone, Federica, additional, Ruggeri, Matteo, additional, Roncadori, Andrea, additional, Baldassarre, Maurizio, additional, Tufoni, Manuel, additional, Zaccherini, Giacomo, additional, Bernardi, Mauro, additional, Domenicali, Marco, additional, Giannone, Ferdinando A, additional, Merli, Manuela, additional, Gioia, Stefania, additional, Fasolato, Silvano, additional, Sticca, Antonietta, additional, Campion, Daniela, additional, Risso, Alessandro, additional, Saracco, Giorgio M, additional, Maiorca, Daniela, additional, Rizzotto, Agostino, additional, Lanzi, Arianna, additional, Neri, Elga, additional, Visani, Anna, additional, Mastroianni, Antonio, additional, Alberti, Alberto B, additional, Mazzarelli, Chiara, additional, Vangeli, Marcello, additional, Marzioni, Marco, additional, Capretti, Francesca, additional, Kostandini, Alba, additional, Magini, Giulia, additional, Colpani, Maria, additional, Laffi, Giacomo, additional, Gabbani, Tommaso, additional, Marsico, Maria, additional, Zappimbulso, Marianna, additional, Petruzzi, Josè, additional, Calvaruso, Vincenza, additional, Parrella, Giovanni, additional, Caporaso, Nicola, additional, Auriemma, Francesco, additional, Guarino, Maria, additional, Pugliese, Fabio, additional, Gasbarrini, Antonio, additional, Leo, Pietro, additional, De Leonardis, Francesco, additional, Pecchioli, Alessandra, additional, Rossi, Piera, additional, Raimondo, Giovanni, additional, Negri, Elisa, additional, Dallio, Marcello, additional, Loguercio, Carmelina, additional, Conte, Dario, additional, Celli, Natascia, additional, Bringiotti, Roberto, additional, Castellaneta, Nicola M, additional, and Salerno, Francesco, additional

Published
2018
Full Text
View/download PDF

45. Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis

Author

Ariza Cardenal, Javier, Graupera, Isabel, Coll, M., Solà, Elsa, Barreto, R., García, E., Moreira, Rebeca, Elia, Chiara, Morales Ruiz, Manuel, Llopis, M., Huelin, Patricia, Solé Padullés, Cristina, Fabrellas i Padrès, Núria, Weiss, E., Nevens, Frederick, Gerbes, A. L. (Alexander L.), Trebicka, Jonel, Saliba, Faouzi, Fondevila Campo, Constantino, Hernández Gea, Virginia, Fernández, J., Bernardi, Mauro, Arroyo, Vicente, Jiménez Povedano, Wladimiro, Deulofeu, Carme, Pavesi, Marco, Angeli, Paolo, Jalan, Rajiv, Moreau, Richard, Sancho Bru, Pau, Ginès i Gibert, Pere, CANONIC Investigators, EASL CLIF Consortium, Universitat de Barcelona, Ariza, X, Graupera, I, Coll, M, Solà, E, Barreto, R, García, E, Moreira, R, Elia, C, Morales-Ruiz, M, Llopis, M, Huelin, P, Solé, C, Fabrellas, N, Weiss, E, Nevens, F, Gerbes, A, Trebicka, J, Saliba, F, Fondevila, C, Hernández-Gea, V, Fernández, J, Bernardi, M, Arroyo, V, Jiménez, W, Deulofeu, C, Pavesi, M, Angeli, P, Jalan, R, Moreau, R, Sancho-Bru, P, and Ginès, P

Subjects
0301 basic medicine, Liver Cirrhosis, medicine.medical_specialty, Cirrhosis, Cirrosi hepàtica, Pronòstic mèdic, Renal function, Lipocalin, Systemic inflammation, Gastroenterology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Lipocalin-2, Acute-on-chronic liver failure, Biomarker, NGAL, Hepatology, Internal medicine, medicine, Humans, Liver injury, Creatinine, Neutrophil gelatinase-associated lipocalin, business.industry, Acute kidney injury, Liver failure, Acute-On-Chronic Liver Failure, Acute Kidney Injury, medicine.disease, Prognosis, 030104 developmental biology, chemistry, Hepatic cirrhosis, Immunology, Biomarker (medicine), 030211 gastroenterology & hepatology, Insuficiència hepàtica, medicine.symptom, business, Biomarkers, cirrhosi
Abstract

BACKGROUND & AIMS: Acute-on-chronic liver failure (ACLF) is a syndrome that occurs in cirrhosis characterized by organ failure(s) and high mortality rate. There are no biomarkers of ACLF. The LCN2 gene and its product, neutrophil gelatinase-associated lipocalin (NGAL), are upregulated in experimental models of liver injury and cultured hepatocytes as a result of injury by toxins or proinflammatory cytokines, particularly Interleukin-6. The aim of this study was to investigate whether NGAL could be a biomarker of ACLF and whether LCN2 gene may be upregulated in the liver in ACLF. METHODS: We analyzed urine and plasma NGAL levels in 716 patients hospitalized for complications of cirrhosis, 148 with ACLF. LCN2 expression was assessed in liver biopsies from 29 additional patients with decompensated cirrhosis with and without ACLF. RESULTS: Urine NGAL was markedly increased in ACLF vs. no ACLF patients (108(35-400) vs. 29(12-73)μg/g creatinine; p

Published
2016

46. EFFECTS OF MICROVESICLES DERIVED FROM BONE MARROW MESENCHYMAL STEM CELLS IN EXPERIMENTAL MODELS OF ALZHEIMER�S DISEASE

Author

ELIA, CHIARA ADRIANA

Abstract

Alzheimer's disease (AD) is the most common form of neurodegenerative illness leading to dementia characterized by the accumulation of abnormally folded ?-Amyloid (A?) and tau proteins, forming amyloid plaques and neurofibrillary tangles, respectively. Recent evidences have highlighted that inflammation plays a critical role in AD, even though it remains unclear whether it represents a cause or a consequence of the pathology. Deposition of A? peptides and tangles are able to stimulate a chronic inflammatory reaction, involving microglial activation and production of inflammatory cytokines likely contributing to neuronal dysfunction and cell death per se. Regarding immunomodulatory strategy development, during the last years, it has been shown that Mesenchymal Stem Cells (MSCs) play a strongly immunomodulatory role, protecting the injured tissue and guiding anti-inflammatory processes by the secretion of cytokines and microvesicles (MVs), involved in their paracrine effects. Furthermore many clinical studies are now performing therapies with MSCs and some phase I and phase II clinical trials in the oncology field are also studying MSC derived MVs (Dai et al, 2008 and Chaput and Th�ry, 2011). Since the possibility that inflammation is not a mere consequence but a primary contributing factor in AD is becoming concrete, and given upregulation of inflammatory molecules (pro-inflammatory cytokines and chemokines) and activated glial cells surrounding the senile plaques in AD patients brains and AD transgenic animal models are now recognized as typical features of AD, the aim of this project is to assess the anti-inflammatory effects of MVs released by Bone Marrow Mesenchymal Stem Cells (BM-MSCs) in an AD context. Both in vitro and in vivo experimental approaches are used to investigate the MV immunomodulatory effect and their ability to affect A? deposition and degradation. Pro- inflammatory (TNF? and IL6) and anti-inflammatory cytokines (IL10) release was investigated by in vitro experiments performed on both microglial N9 cell line and on primary cortical cells exposed to human-A?1-42 (h- A?1-42 ) and MSC derived MVs. For a more complete analysis of the cell inflammatory state, the microglia phenotype was assessed in order to determine whether a change from M1 to M2 cell phenotype was detectable. The in vivo approach consisted of MV intracranial injections in a well-established transgenic AD chimeric murine model (APPswe/PS1dE9) that recapitulates many of the aspects of the human disease; to investigate whether MVs effects could be effective on the clearance and production of A?, possibly ameliorating the neurodegenerative context, we analyzed A? load, plaque area and density in three different brain areas: cerebral cortex, hippocampus and cerebellum. The results obtained in vitro indicate that i) the administration of MVs promotes in vitro the secretion of anti-inflammatory cytokines, such as IL10; ii) MVs promote the switch of microglial cell to M2 phenotype, characterized by the typical amoeboid morphology, and increase the expression of CD206, a marker associated to the anti-inflammatory abilities; iii) MV administration significantly inhibits the release of the pro- inflammatory cytokines TNF? and IL 6 in vitro and accordingly, MHC II expression, which is associated with a pro-inflammatory phenotype, is down regulated in the presence of MSC-MVs. On the other hand, in vivo results show that a single MV administration causes a significant reduction of A? load into amyloid plaques and a decreased plaque area, into all three brain regions analyzed in 6 month old mice. In 3 month old treated mice, MV administration only affected A? plaque density, that resulted smaller respect to untreated mice. In conclusion, MVs released from BM-derived MSCs can exert, in vivo, a protective effect reducing the accumulation in plaques of A?, possibly promoting the degradation and elimination of A?42 and participating in the regulation of neuroinflammation. Future experiments will be directed to assess the safety of MV administration and to define whether a significant improvement of cognitive impairment is detectable in AD mice treated with BM-derived MSCs . ?

Published
2016
Full Text
View/download PDF

47. Evaluation of Clensia ® , a new low-volume PEG bowel preparation in colonoscopy: Multicentre randomized controlled trial versus 4L PEG

Author

Spada, Cristiano, primary, Cesaro, Paola, additional, Bazzoli, Franco, additional, Saracco, Giorgio Maria, additional, Cipolletta, Livio, additional, Buri, Luigi, additional, Crosta, Cristiano, additional, Petruzziello, Lucio, additional, Ceroni, Liza, additional, Fuccio, Lorenzo, additional, Giordanino, Chiara, additional, Elia, Chiara, additional, Rotondano, Gianluca, additional, Bianco, Maria A., additional, Simeth, Catrin, additional, Consalvo, Danilo, additional, De Roberto, Giuseppe, additional, Fiori, Giancarla, additional, Campanale, Mariachiara, additional, and Costamagna, Guido, additional

Published
2017
Full Text
View/download PDF

48. Adipocyte Fatty-Acid Binding Protein is Overexpressed in Cirrhosis and Correlates with Clinical Outcomes

Author

Graupera, Isabel, primary, Coll, Mar, additional, Pose, Elisa, additional, Elia, Chiara, additional, Piano, Salvatore, additional, Solà, Elsa, additional, Blaya, Delia, additional, Huelin, Patricia, additional, Solé, Cristina, additional, Moreira, Rebeca, additional, de Prada, Gloria, additional, Fabrellas, Núria, additional, Juanola, Adrià, additional, Morales-Ruiz, Manuel, additional, Sancho-Bru, Pau, additional, Villanueva, Càndid, additional, and Ginès, Pere, additional

Published
2017
Full Text
View/download PDF

50. Effects of alfapump™ system on kidney and circulatory function in patients with cirrhosis and refractory ascites

Author

Solà, Elsa, primary, Sanchez‐Cabús, Santiago, additional, Rodriguez, Ezequiel, additional, Elia, Chiara, additional, Cela, Raquel, additional, Moreira, Rebeca, additional, Pose, Elisa, additional, Sánchez‐Delgado, Jordi, additional, Cañete, Nuria, additional, Morales‐Ruiz, Manuel, additional, Campos, Francisco, additional, Balust, Jaume, additional, Guevara, Mónica, additional, García‐Valdecasas, Juan Carlos, additional, and Ginès, Pere, additional

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results